[1]Lettersindrugdesignanddiscovery,2016,vol.13,p.198-204
[2]Patent:WO2011/54841,2011,A1.Locationinpatent:Page/Pagecolumn76
[3]Patent:US2012/208798,2012,A1.Locationinpatent:Page/Pagecolumn33
1170019-97-2
1170108-38-9
1173206-71-7
1158758-77-0
1158758-85-0
1235439-71-0
1239771-67-5 | (3-Methyl-1,2,4-oxadiazol-5-yl)acetonitrile | AA00AA0H | MFCD16874897
17595-92-5 | 2-(2-METHOXYPHENYL)THIOPHENE | AA00AAWV | MFCD06801787
18228-17-6 | NAPHTHOL AS-E PHOSPHATE | AA00AB5D | MFCD00042718
193022-04-7 | CTS-1027 | AA00ABGS | MFCD16657131
171500-79-1 | Dalbavancin | AA00ABKT | MFCD09837770
1910124-24-1 | Gsk6853 | AA00ABPJ | MFCD30489734
17117-19-0 | 3-Bromo-2,5-dimethylpyridine | AA00ABZG | MFCD00234306
18413-14-4 | Ethylhydrazine hydrochloride | AA00ACA3 | MFCD01722460
1684-47-5 | BENZENE (1,3,5-D3) | AA00ACOL | MFCD00075275
153334-29-3 | 1-(1H-1,2,4-Triazol-5-yl)ethanone | AA00ACUO | MFCD17078875